Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q89505017
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010858.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q89505017
|
024
|
|
|
‡a
0000-0003-0707-5294
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q89505017
|
100
|
0 |
|
‡a
Erin Diane Kennedy
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Erin Diane Kennedy
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis
|
670
|
|
|
‡a
Author's The Canadian Partnership Against Cancer Rectal Cancer Project: Protocol for a Pan-Canadian, Multidisciplinary Quality Improvement Initiative to Optimize the Quality of Rectal Cancer Care
|
909
|
|
|
‡a
(orcid) 0000000307075294
‡9
1
|
919
|
|
|
‡a
realworldoutcomesoffolfirinoxvsgemcitabineandnabpaclitaxelinadvancedpancreaticcancerapopulationbasedpropensityscoreweightedanalysis
‡A
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis
‡9
1
|
919
|
|
|
‡a
canadianpartnershipagainstcancerrectalcancerprojectprotocolforapancanadianmultidisciplinaryqualityimprovementinitiativetooptimizethequalityofrectalcancercare
‡A
The Canadian Partnership Against Cancer Rectal Cancer Project: Protocol for a Pan-Canadian, Multidisciplinary Quality Improvement Initiative to Optimize the Quality of Rectal Cancer Care
‡9
1
|
996
|
|
|
‡2
BIBSYS|90119709
|
996
|
|
|
‡2
BAV|495_234711
|
996
|
|
|
‡2
LC|n 85288372
|
996
|
|
|
‡2
LC|n 80010557
|
996
|
|
|
‡2
BIBSYS|90721854
|
996
|
|
|
‡2
BIBSYS|90290649
|
996
|
|
|
‡2
ISNI|0000000025613074
|
996
|
|
|
‡2
NTA|072643803
|
996
|
|
|
‡2
LC|no2005035226
|
996
|
|
|
‡2
ISNI|0000000043604657
|
996
|
|
|
‡2
ISNI|0000000028893219
|
996
|
|
|
‡2
N6I|vtls000018134
|
996
|
|
|
‡2
BIBSYS|90886658
|
996
|
|
|
‡2
LC|n 85136259
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|